Invesco Health Care Y (GGHYX)

Fund Assets	1.21B
Expense Ratio	0.82%
Min. Investment	$1,000
Turnover	59.00%
Dividend (ttm)	2.20
Dividend Yield	4.98%
Dividend Growth	20.01%
Payout Frequency	n/a
Ex-Dividend Date	Dec 18, 2025

Previous Close	44.40
YTD Return	8.77%
1-Year Return	20.49%
5-Year Return	18.39%
52-Week Low	36.96
52-Week High	45.04
Beta (5Y)	0.80
Holdings	80
Inception Date	Oct 3, 2008

About GGHYX

The Invesco Health Care Fund Class Y is an actively managed mutual fund specializing in the health care sector. Its primary objective is to provide long-term capital growth by investing in equity securities of leading health care companies around the world. The fund holds a diversified portfolio, with a significant emphasis on U.S.-based health care firms but also includes notable positions in international companies. Core portfolio allocations span across key industry segments such as health care equipment, biotechnology, pharmaceuticals, life sciences tools and services, health care facilities, and managed health care. The fund typically invests in industry leaders with strong management teams and a demonstrated track record of innovation and operational excellence. With around 70-80 individual holdings and over $1 billion in assets under management, it serves as a targeted option for investors seeking exposure to the dynamics and growth potential within global health care markets. Fund management emphasizes rigorous stock selection, leveraging in-depth sector expertise to navigate industry risks including regulatory changes, pricing pressures, and technological disruptions.

• Fund Family: Invesco
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: GGHYX
• Share Class: Class Y
• Index: S&P Composite 1500 Health Care TR

Performance

GGHYX had a total return of 20.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.80%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
GTHIX	Investor Class	1.07%
GGHCX	Class A	1.07%
GTHRX	Class R	1.32%
GTHCX	Class C	1.82%

Top 10 Holdings

46.66% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.84%
Johnson & Johnson	JNJ	6.32%
UnitedHealth Group Incorporated	UNH	6.06%
Merck & Co., Inc.	MRK	4.18%
argenx SE	ARGX	3.99%
AbbVie Inc.	ABBV	3.96%
Gilead Sciences, Inc.	GILD	3.46%
AstraZeneca PLC	AZN	2.90%
BrightSpring Health Services, Inc.	BTSG	2.73%
Welltower Inc.	WELL	2.22%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$2.2025	Dec 18, 2025
Dec 16, 2024	$1.8353	Dec 16, 2024
Dec 16, 2021	$9.9297	Dec 16, 2021
Dec 15, 2020	$0.5793	Dec 15, 2020
Dec 13, 2019	$1.5683	Dec 13, 2019
Dec 14, 2018	$2.9024	Dec 14, 2018

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error